Biointron Weekly Reports

Biointron Weekly Reports

News?

In our latest episode of the Antibody Basics video series (Part 7), we cover how antibodies became the basis of life-saving therapeutics. We describe various functions including neutralization, opsonization, agglutination, complement activation, and ADCC. Watch it now.?

Biointron’s Q1 2024 Antibody Industry Report is out now! Dive into the latest trends, breakthroughs, and insights shaping the antibody industry. Gain exclusive insights into:?

  • ?? Top 10 antibody drug deals, including M&As, partnerships, and funding rounds of up to $10.1B?

  • ?? Antibody drugs and clinical trials to watch in 2024?

  • ?? A focus on hot antibody startups launching from stealth mode with up to $150M in funding?

  • ?? Trends in ADCs for oncology, such as Enhertu and Kadcyla raking in over $2B in sales last year?

  • ?? Updates on the battle for therapies for Alzheimer’s: Lecanemab, Donanemab, and Trontinemab??

Download the full report for free here.?


This Week’s News?

  • Roundup of the latest antibody biotech deals from the past month, including a $208M ADC deal?

  • One-time treatment restores aging mouse immune system via antibody-mediated depletion of my-haematopoietic stem cells (HSCs)?

  • Monoclonal antibodies engineered by a new lipid nanoparticle (LNP)-encapsulated mRNA platform, offering a potential solution to combat orthopoxviruses?


Trends – Immunosenescence?

DOI: 10.3389/fimmu.2020.579220

As we age, our innate and adaptive immune system undergoes various changes, typically characterized by decreased lymphopoiesis and adaptive immunity, and increased inflammation and myeloid pathologies. Immunosenescence (the gradual deterioration of the immune system associated with ageing), makes individuals more susceptible to infections, less responsive to vaccines, and prone to the development of chronic inflammatory conditions and autoimmune diseases. Additionally, age-related alterations in the composition and function of the microbiota, the community of microorganisms living in and on the body, can further influence immune function and contribute to the overall ageing process.?

This month, several papers related to antibodies and aging were published, including a?comprehensive review by Quiros-Roldan et al., studying the impact of immune system aging on infectious diseases, including the progressive reduction of the body’s ability to trigger effective antibody responses. Here they describe the increased public interest in immune system aging due to prolonged life expectancy, contrasted to health expectancy. They also provide an analysis of the immune players involved, in addition to immune cells/mediators within endogenous and exogenous factors and co-morbidities.?

Another paper this month provides insight into why age is a major risk factor for severe COVID-19. By evaluating the impact of aging and anti-IFN autoantibodies on host immune response in the blood, upper airway, and nasal microbiome, the researchers found that older age correlated with impaired viral clearance, dysregulated immune signaling, and persistent and potentially pathologic activation of pro-inflammatory genes and proteins. ?

Ending on a bright note,?Ross et al.’s study in Nature demonstrates the antibody-mediated depletion of my-haematopoietic stem cells (HSCs) in aged mice restores characteristic features of a more youthful immune system. Their findings show it might be possible to reverse the ageing phenotype by eliminating my-HSCs in aged mice and contributes to the understanding and intervention of diseases exacerbated or caused by dominance of the haematopoietic system by my-HSCs.?

?

Promotions?

Biointron offers a new choice for your small-scale antibody expression rush needs: RushMab? Small-Scale Antibody Expression Packages.?

?? Designed to be cost-effective and time-saving?

? As fast as 8 days?

?? More than 5000 samples?

?? Explore different packages from Super, Standard, and Mini?

?

Upcoming Events?

Next month, we will have several events, including:?

  1. BIO KOREA 2024 on May 8-10 at COEX in Seoul, Korea. Find us at Booth #36!?
  2. Chinese Antibody Society 2024 Annual Meeting on May 11 in Cambridge, MA. Schedule 1-on-1 time!?
  3. PEGS Boston (Protein & Antibody Engineering Summit) on May 13-17 at Boston, MA. Find us at Booth #613!?

We will also be hosting our very first Lunch & Learn on May 9, at MassBioHub in Boston, MA! Featuring our SVP of R&D, Lei Shi , PhD, and special guest speaker Victor Goldmacher , the session will focus on advancements in next-generation HTP antibody development in the biopharma industry and unlocking hidden efficiencies ??.?


New Products & Reports?

?

Learn more about Biointron at www.biointron.com, or contact us at [email protected] and +1 (732) 790-8340.??

要查看或添加评论,请登录

社区洞察

其他会员也浏览了